Acute Stroke Imaging

Published on 12/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3630 times

Chapter 3 Acute Stroke Imaging

There was a time, not too long ago, when acute brain imaging in patients with suspected stroke was thought to be useful only to exclude hemorrhage or obvious stroke mimickers, such as tumors. The introduction of effective acute stroke therapies changed this conception completely, however. Today emergency brain imaging is essential for the management of acute stroke patients. We have learned that computed tomography (CT) scans can offer valuable information even when obtained within the first few hours of the ischemic event (dispelling the notion that CT scans are not useful for ischemic strokes until 1 or 2 days after onset). New CT-based protocols, including CT perfusion (CTP) scans and CT angiograms, are rapidly gaining ground in clinical practice. Diffusion-weighted and perfusion-weighted (DWI and PWI) magnetic resonance imaging (MRI) provide the ability to depict the penumbra and promise expansion of the therapeutic window for vessel opening on individual cases based on the subsistence of salvageable tissue. Conventional angiography has been transformed from a purely diagnostic test into a means for therapeutic intervention. Even transcranial Doppler may have an important role in the emergent evaluation and management of acute ischemic stroke, providing proof of large intracranial vessel occlusion and possibly improving the chances of recanalization with thrombolysis when continuous insonation is employed.

The uses of various neuroimaging techniques in acute stroke are multiple and continue to expand. The most common current indications and purposes of acute neuroimaging in stroke patients are listed in Table 3-1.

TABLE 3-1 Indications and purposes of emergency neuroimaging in patients with suspected acute ischemic stroke

Indication/purpose Imaging modality
Confirmation of diagnosis (TIA vs. stroke vs. stroke mimics) CT/MRI
Differentiation of ischemia vs. hemorrhage CT/MRI
Visualization of established infarction (as contraindication for thrombolysis) CT
Localization of ischemia/stroke pattern (which may guide evaluation of stroke mechanism) CT/MRI
Evaluation of penumbra (which may extend therapeutic window for acute revascularization) DWI-PWI/CTP
Identification of early prognostic markers (e.g., HDMCA sign, extensive high ASPECTS score, large volume of DWI restriction) CT/MRI
Visualization of arterial site of occlusion MRA/CTA/catheter angiography
Documentation of recanalization MRA/CTA/catheter angiography/TCD
US-assisted intravenous thrombolysis TCD
Access and information to make endovascular treatment possible Catheter angiography

ASPECTS, Alberta Stroke Program Early CT Score; CT, computed tomography; CTA, CT angiography; CTP, CT perfusion; DWI, diffusion-weighted imaging; HDMCA, hyperdense middle cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; PWI, perfusion-weighted imaging; TCD, transcranial Doppler; TIA, transient ischemic attack; US, ultrasound.

This chapter illustrates and summarizes the multiple values of brain imaging in the acute phase of ischemic stroke and concludes with a succinct discussion on the radiological features of subacute and chronic infarctions that allow timing of ischemic strokes.

COMPUTED TOMOGRAPHY

CT Signs of Acute Ischemia

It is important to discriminate signs of brain edema, such as loss of insular ribbon (Figure 3-3), obscuration of lenticular nucleus (Figure 3-4), loss of gray–white matter differentiation, and sulcal effacement (Figure 3-5) from areas of hypoattenuation, because only the latter represents irreversible damage (established infarction).3,4
Interobserver agreement for the recognition of early ischemic changes is only fair when performed without following a formal method and without considering the clinical information.5,6 Thus it is crucial to know the expected location of the ischemic insult on the basis of the information provided by the history and physical examination and to follow a methodical approach to maximize the yield of CT scan interpretation. Modifications of window settings may also increase the sensitivity of CT scanning to detect early ischemic changes (Figure 3-6).7
Visual identification of early signs of ischemia (particularly hypoattenuation) involving more than one third of the estimated middle cerebral artery (MCA) territory was considered an exclusion criterion for enrollment in several thrombolysis trials, most notably those conducted by the European Acute Stroke Study (ECASS) investigators,8,9 on the basis of a reasonable but unproved assumption that patients with early signs of extensive ischemia would have higher risk of bleeding after thrombolysis. However, this preconception was not validated by the analysis of the radiological data from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA study, which did not include this radiological exclusion criterion.10 In this trial, ischemic changes on baseline CT scan were observed in 31% of patients. They correlated with greater severity of initial clinical deficits and with longer time from symptom onset but were not independently associated with functional outcome after controlling for other baseline variables. Early ischemic changes were not associated with clinical deterioration within the first 24 hours or symptomatic intracranial hemorrhage within the first 36 hours in the adjusted analysis.11
Moreover, although there is some evidence that extensive early ischemic changes may portend higher risk of intracerebral hemorrhage,12 there is no proof that the extension of early ischemic changes significantly affects the chances of functional recovery after thrombolysis.12,13
Nonetheless, most current acute stroke management guidelines include extensive early signs of ischemia as a contraindication for thrombolysis. The guidelines sponsored by the American Heart Association indicate that thrombolysis should not be used if the baseline CT scan shows multilobar hypodensity involving more than one third of the cerebral hemisphere.1 This carefully crafted recommendation appears prudent. It is important to notice that it intentionally indicates hypodensity (as opposed to other early signs that may represent only tissue swelling and are more difficult to identify) and eliminates the need to estimate the MCA territory as a parameter to define the extension of the changes. On the basis of current evidence, withholding thrombolysis in patients with early signs of tissue edema but no large hypodensities is not justified.
The extension of ischemic changes in the territory of the middle cerebral artery can be quantified using the Alberta Stroke Program Early CT Score (ASPECTS) (Figures 3-7 and 3-8), a 10-point topographic scoring system that has been shown to be easy to use in real time with moderately good interrater reliability.2,14,15 A cutoff score of less than 7 points is most useful to determine ischemia involving more than one third of the MCA territory.15 Notice that this score can only be used in cases of middle cerebral artery ischemia.
The hyperdense MCA sign on baseline CT scan has been found to be associated with poor prognosis17,18 and a higher risk of hemorrhage after thrombolysis.19 The combination of hyperdense MCA sign and extensive sulcal effacement predicts massive swelling and brain herniation.20 Conversely, early resolution of the hyperdensity in the MCA indicates successful reperfusion and is associated with favorable outcome after thrombolysis.
Intravenous thrombolysis can be beneficial in patients presenting with the hyperdense MCA sign.18 However, when the hyperdense signal appears to involve the carotid terminus in a patient with signs suspicious for carotid bifurcation occlusion (depressed arousal, severe leg weakness), it may be more effective to pursue intra-arterial therapy directly if this is a pragmatically feasible option.21
Distal thrombi can sometimes be visualized generating the Sylvian fissure “dot” sign (Figure 3-9, C).22 Its sensitivity is modest (close to 40%), but when identified, it is very specific in predicting M2 or M3 branch occlusion.23 The dot sign is associated with better outcome than more proximal hyperdense vessel signals.22

TABLE 3-2 Early signs of ischemic stroke on brain CT scan.

Sign Significance
Hyperdense vessel sign Intraluminal thrombus
Loss of insular ribbon Focal tissue edema
Obscuration of the lenticular nucleus Focal tissue edema
Loss of gray–white matter distinction Focal tissue edema
Sulcal effacement Focal tissue edema
Areas of hypoattenuation Tissue infarction

CT Perfusion

There is growing interest in the application of CT protocols using multimodal CT scanning (CT scan, CT perfusion, and CT angiogram) for the emergency diagnosis and management of ischemic stroke.3,25 The most attractive features of CT perfusion imaging are its potential for widespread availability (it can be performed on any standard helical CT scanner) and the short time required for the acquisition of data (with adequate training, CT perfusion and CT angiogram can be acquired in 15–20 minutes, and images can be processed and interpreted in 10 minutes or less).26,27
Prolonged relative MTT and delayed relative TTP are the most sensitive physiological parameters to detect hypoperfusion.28 These measures correlate well with MRI abnormalities on PWI and accurately predict final infarct volume in patients who have persistent arterial occlusions (Figure 3-10).29,30 Meanwhile, reduced absolute CBV (or reduced relative CBV by visual inspection) is the best indicator of established infarction; it correlates well with DWI lesions on MRI and with final infarct size in patients who recanalize.2830 The product CBF × CBV may have greater diagnostic accuracy than CBV alone, but this requires the use of quantitative measures.31

TABLE 3-3 Relative advantages of CT perfusion and DWI-PWI MRI for the assessment of ischemic penumbra.

CT perfusion
Easier access
Rapid acquisition of images
Robust quantitative physiological measurements
Feasible in patients with contraindication for MRI
DWI-PWI MRI
May be easier to visualize the penumbra
Depiction of cellular edema
Greater spatial resolution (whole brain imaging)
Does not require iodine contrast

CT, computed tomography; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; PWI, perfusion-weighted imaging.

CT Angiogram

CT angiography has been shown to be safe.27 Renal complications related to contrast administration are exceptional and almost uniformly reversible.
The source images of CT angiography have been used to estimate perfusion deficits (Figure 3-12 serves as example).35 The advantages of this method over dynamic CT perfusion imaging include visualization of the whole brain and use of a single bolus of contrast material.3 However, this application has not been validated, and its sensitivity is likely to be poorer than those of CT perfusion or DWI-PWI.

MAGNETIC RESONANCE IMAGING

Although MRI scans provide better anatomical definition for the recognition of ischemic lesions than CT (particularly for small infarctions and strokes in the brainstem and posterior fossa), the added expense of MRI was deemed unjustified in the acute stroke setting until the introduction of physiological sequences: diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI). These new sequences are extremely valuable tools for the acute diagnosis of ischemic stroke and offer promise to expand the therapeutic window for recanalization. Equally important are the advances in our understanding of stroke pathophysiology facilitated by the information afforded by these imaging techniques.

Furthermore, MRI (with DWI and susceptibility weighted sequence) has been proved superior to CT scanning for the detection of acute ischemia and chronic hemorrhage and at least comparable to CT for the diagnosis of acute hemorrhage.36 Thus solid arguments support the use of MRI as the primary imaging modality for the emergency evaluation of acute stroke patients if the study can be performed without delay.

Diffusion-Weighted and Perfusion-Weighted Imaging

Areas with restricted diffusion due to cellular edema are hyperintense on the DWI sequence and hypointense on the apparent diffusion coefficient (ADC) map (Figure 3-13). The ADC value quantifies diffusion; the lower the value, the greater the restriction of motion of water molecules. Conversely, high ADC values are observed in areas of vasogenic edema and chronic infarction in which water molecules have freedom of motion.
Table 3-4 lists the practical values of DWI in the evaluation of acute stroke patients.

TABLE 3-4 Main practical uses of DWI in patients with acute stroke presentation.

Hyperacute and acute diagnostic confirmation of ischemic stroke
Differentiation of acute vs. subacute vs. chronic ischemic lesions
Assessment of ischemic penumbra (in combination with PWI)
Acute differential diagnosis between TIA and minor stroke with reversible neurological deficits
Distinction of cytotoxic and vasogenic edema (in conditions such as eclampsia or hyperperfusion syndrome)
Identification of patients at risk of severe reperfusion hemorrhage

DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; PWI, perfusion-weighted imaging; TIA, transient ischemic attack.

PWI-DWI Mismatch

A TTP delay greater than 4 seconds relative to the contralateral hemisphere appears to be the best marker of the penumbra.48 Nonetheless, this measure may overestimate the size of penumbra in some cases.48 CBF maps most closely identify the final infarct volume.49,50
The ischemic penumbra is represented on MRI by the perfusion-diffusion (PWI-DWI) mismatch (Figures 3-11, 3-16, and 3-17). The PWI lesion corresponds to the area of hypoperfusion and the DWI lesion to the ischemic core.
Unfortunately, there is no validated definition of PWI-DWI mismatch.52 Different definitions have been used in published studies, and visual estimates are most commonly used in practice for acute decision making.
In theory, the DWI lesion can expand to reach the size of the initial PWI deficit unless reperfusion occurs. However, confirmation of this hypothesis has proved elusive at times. In fact, some studies have shown that mismatch volume may fail to correlate with DWI lesion expansion.50,53 Possible explanations for this lack of correlation are that areas of ischemia are highly heterogeneous,54 DWI lesions may be reversible (normalization of ADC values has been noted in some patients after thrombolysis),55 and PWI lesions actually incorporate regions of true penumbra and regions of reversible oligemia.56
Determining whether PWI-DWI mismatch can be reliably used to identify salvageable tissue is of major practical importance. Because DWI expansion can be prevented by early reperfusion regardless of the presence of PWI-DWI mismatch,53 there is no indication for MRI before administering intravenous thrombolysis within 3 hours of symptom onset (there are some data suggesting greater safety for thrombolysis within 3 hours in patients selected with MRI vs. those only evaluated with CT scan,57 but not enough solid evidence to change current practice guidelines). However, all other acute revascularization treatments are not the standard of care, and there is considerable interest in developing imaging protocols to guide their application (penumbra-based protocols). MRI protocols have been used in research trials to select candidates for intravenous thrombolysis beyond the currently accepted therapeutic window.58,59
In a recent prospective, multicenter study of ischemic stroke patients treated with intravenous thrombolysis between 3 and 6 hours after symptom onset, those patients with larger PWI-DWI mismatch had greater likelihood of favorable clinical outcome after reperfusion.60 In this same study, patients with very large DWI or PWI lesion volumes had very high risk of fatal hemorrhagic conversion after reperfusion.60 Thus MRI profiles may help identify the best and worst candidates for revascularization therapy beyond 3 hours.52
In centers in which PWI has not been standardized, clinicians may rely on the clinical-radiological mismatch, understood as the discrepancy between relatively small DWI lesions and severe clinical deficits (Figure 3-18).62 These patients are likely to have large areas of penumbra in which brain tissue is dysfunctional (hence the severe clinical deficits) but salvageable (hence the relatively small DWI lesion). This clinical-radiological mismatch has been found to predict the presence of PWI-DWI mismatch with high specificity, although low sensitivity.63

Direct Thrombus Visualization

The susceptibility vessel sign on T2* sequence may actually identify fibrin-rich emboli (more likely to be originated by a cardiac source).65 It is unclear whether this sign may predict greater likelihood of recanalization, a notion supported by some studies65 but not by others.66 Disappearance of the sign on follow-up MRI after thrombolysis correlates with recanalization but does not necessarily portend favorable clinical outcome.67

MAGNETIC RESONANCE ANGIOGRAPHY

Magnetic resonance angiography (MRA) can be valuable in the acute setting to determine the actual site of the vascular occlusion (see Figure 3-18) and to assess whether the vessel was successfully opened after noninvasive revascularization treatments (Figure 3-20).
It is important to be aware that saturation artifact may produce loss of signal, which may be misinterpreted as occlusion. This type of artifact occurs because whereas blood flow perpendicular to the plane of application of radiofrequency pulses is exposed briefly to these pulses and can be well imaged, blood flowing in the same plane as the angle of imaging is exposed to an excessive amount of radiofrequency pulses, leading to saturation and signal loss.68 Saturation artifact is commonly encountered at the levels of the horizontal turns of the vertebral arteries and in the knees of the petrous carotid arteries, but it can also be found in distal branches of the circle of Willis, where it can be more deceiving. Contrast-enhanced images may improve accuracy in the assessment of patency of distal arterial branches.69

IMAGING IN STROKE EMERGENCIES

Intravenous Thrombolysis

The likelihood of recanalization with intravenous thrombolysis may be increased by combining it with continuous insonation of the site of the occlusion using TCD.74 A Phase II trial evaluating this approach showed promising results. However, correct application of this combined therapeutic modality is labor intensive and requires TCD expertise. TCD may also be used to diagnose early reocclusion after initially successful recanalization; this finding is strongly predictive of clinical decline and poor functional outcome.75

Intra-Arterial Revascularization Therapies

Case Vignette

A 52-year-old woman presented to a local hospital with acute aphasia and right hemiplegia. CT scan was negative for hemorrhage, and she was referred to our academic hospital for acute management. Upon arrival to our emergency department 3 hours and 30 minutes after symptom onset, her examination revealed global aphasia, left gaze preference, right homonymous hemianopia, paralysis of the lower right face and the right arm, comparatively milder weakness of the right leg, and right hemihypoesthesia. Her initial National Institutes of Health Stroke Scale score (NIHSS) was 20. Because she was outside of the accepted therapeutic window for intravenous thrombolysis, she was immediately taken to the angiographic suite. Digital subtraction angiography demonstrated a proximal occlusion of the M1 segment of the left middle cerebral artery. Intra-arterial infusion of the rt-PA (22 mg) combined with mechanical disruption of the clot and subsequent angioplasty of the previously occluded segment resulted in successful vessel recanalization (Figure 3-21). Over the following 24 hours, the patient recovered substantially from her initially severe deficits. Repeat brain imaging only showed a small left periopercular infarction. Her NIHSS at discharge was 4, and after a few weeks of outpatient rehabilitation, she was able to return to work with no functional restrictions.

The rate of symptomatic complications in the MERCI trial has been acceptable (7.8%–9.8% rate of symptomatic ICH).7779 The possibility of vessel wall perforation was a major concern with the first generation of the device,77 but the newer generation (L5 Retriever) has proved substantially safer.78,79 Nonetheless, procedural complications still occur in more than 5% of cases.79
There is considerable interest in exploring the therapeutic option of pursuing intra-arterial thrombolysis in patients who fail to recanalize after receiving a bridging dose (0.6 mg/kg as opposed to the full dose of 0.9 mg/kg) of intravenous rt-PA within the first 3 hours of deficits.80 This approach has been proven feasible and relatively safe in a Phase II trial that showed promising clinical results in patients with severe strokes at presentation;81 a Phase III trial is underway.
Aggressive mechanical clot disruption, often attempted in practice along with intra-arterial thrombolysis, may increase the rate of recanalization in patients with large intracranial vessel occlusion.82 The most commonly used technique consists of trying to macerate the clot by repeat passes of the microwire or microcatheter. Acute angioplasty (with or without stenting) of the vessel may be successful in selected patients with resistant occlusions,83 as illustrated by our case (Figure 3-21).
Intra-arterial (or intravenous) IIb–IIIa antagonists may be used as part of a multimodality approach.84 Perhaps the most valuable role of these agents is preventing reocclusion of a partially recanalized vessel. Excellent results with the use of these agents for the treatment of acute thromboembolic complications during neuroendovascular procedures have been reported.85

Massive Hemispheric Infarction

Case Vignette

A 44-year-old woman was found collapsed in her apartment by her neighbor and brought emergently to the hospital. On examination, she was awake but incoherent. She had left hemianopia, hemiplegia, hyperreflexia, Babinski sign, and hemineglect. CT scan of the brain confirmed the presence of extensive infarction in the right middle cerebral artery territory (Figure 3-23, A). The patient was carefully monitored in the stroke unit, and 36 hours later, she was noticed to have difficulty opening her eyes despite being awake and able to follow other commands (cerebral ptosis). She had also developed Babinski sign on the right side (i.e., ipsilateral to the infarcted hemisphere). Repeat CT scan showed progression of mass effect and midline shift (Figure 3-23, B). Forty-two hours after admission, she became less arousable, and a new CT scan disclosed a 15-mm displacement of the septum pellucidum (Figure 3-23, C). Her pupils remained isocoric and reactive to light. She was intubated, hyperventilated, treated with 1 g/kg of 20% mannitol, and taken to the operating room. Decompressive hemicraniectomy and duroplasty were performed without complications. Repeat CT scan 18 hours after surgery demonstrated outward brain herniation through the site of craniectomy with partial improvement in the midline shift (Figure 3-23, D). The patient’s level of consciousness improved after surgery and did not decline again. Six months after the stroke, she had achieved meaningful functional recovery, with moderate residual disability. She underwent replacement of the bone flap with no complications.

Some clinical signs, such as the development of cerebral ptosis97 or ipsilateral Babinski sign, and serial CT scans to monitor the progression of midline shift may be helpful to guide the timing of hemicraniectomy. However, other neuroimaging techniques may allow earlier prediction of malignant edema formation. Deficit of ligand uptake throughout the whole MCA territory on 99m ethylcysteinate-single photon emission CT (SPECT) within 6 hours of stroke onset98 and 99m diethylenetriaminepentaacetic-SPECT imaging at 36 hours demonstrating extensive disruption of blood brain barrier permeability99 have been reported to predict malignant infarction with high reliability. Unfortunately, these techniques are not widely available at present.

Acute Internal Carotid Artery Occlusion

Basilar Artery Occlusion

Case Vignette

A 52-year-old man with history of uncontrolled hypertension, diabetes, hyperlipidemia, and smoking was admitted with bilateral acute cerebellar infarctions. Brain MRI (Figure 3-25, A-D) confirmed the areas of cerebellar ischemia and also showed changes consistent with acute basilar trunk occlusion (hyperintense vessel signal on FLAIR and absent basilar flow on MRA, which allowed visualization of bilaterally patent posterior communicating arteries). During the first day, the patient remained stable on intravenous crystalloids, colloids, and heparin. The following morning, however, he became more difficult to arouse, and he developed diplopia with disconjugate gaze and worsening bilateral weakness. Dopamine infusion was initiated to elevate his blood pressure resulting in partial improvement of his new deficits. He then underwent emergent catheter angiography, which demonstrated a proximal occlusion of the basilar artery (Figure 3-25, E). The patient was treated with mechanical clot disruption and angioplasty of the basilar artery with excellent radiographic results (Figure 3-25, F and G). After the procedure, his deficits improved, and he was discharged home 10 days later with residual ataxia. His residual deficits continued to improve steadily over the following year. Three years later, the patient remained free of recurrent ischemic neurological symptoms, and his basilar artery remained widely patent on follow-up noninvasive angiography.

In patients with basilar thrombosis, revascularization may be compatible with favorable functional outcomes even if achieved after 12 hours or more from the onset of deficits.102 This is the case because midbasilar thrombotic occlusions often present with progressive symptoms (indicative of worsening compromise of perfusion) before irreversible ischemia ensues.103
Intra-arterial thrombolysis, mechanical embolectomy, and acute angioplasty and stenting are the best treatment options in these situations.83,102,104,105 However, intravenous thrombolysis can be successful in patients presenting within 3 hours of symptom onset106,107 and probably represents the treatment of choice in cases of top-of-the-basilar syndrome evaluated within this time window.

Massive Cerebellar Infarction

Case Vignette

A 42-year-old woman with history of hypertension and diabetes presented with sudden onset of acute ataxia. Brain imaging (CT scan and MRI) disclosed patchy cerebellar infarctions, mostly involving the right posterior inferior cerebellar artery territory (Figure 3-27, A and B). MRA of the intracranial circulation revealed occlusion of the right vertebral artery (Figure 3-27, C). The following day, the patient was clinically stable, but swelling of the infarction was already evident on repeat CT scan (Figure 3-27, D). Early on the third hospital day, she became drowsy and developed new right facial and abducens palsies. A new CT scan revealed further progression of mass effect (Figure 3-27, E). She underwent emergency suboccipital craniectomy. After surgery, her level of consciousness improved, but her right esotropia persisted. Postsurgical imaging confirmed adequate decompression (Figure 3-27, F). Although no additional complications occurred during the rest of the hospitalization, her functional recovery was limited.

The causes of deterioration from progression of mass effect in patients with cerebellar infarctions are similar to those observed in cases of cerebellar hematomas’namely, direct brainstem compression (Figure 3-27), obstructive hydrocephalus from compression of the fourth ventricle (Figure 3-28, A and B), and aqueductal occlusion from upward herniation of the vermis through the tentorial notch (Figure 3-28, C and D). Apart from edema, sudden increment in mass effect can be produced by hemorrhagic conversion of the ischemic infarction. All of these mechanisms may be reliably diagnosed and differentiated by brain imaging, allowing timely surgical intervention when necessary.109
Our case also illustrates that surgical management with suboccipital craniectomy may preserve life and function in deteriorating patients.108,110 External ventricular drainage should probably be avoided in patients with radiological signs of upward herniation because it may exacerbate the tissue displacement in these cases.

Subacute and Chronic Infarctions

On contrast scans, patchy or gyral enhancement begins to appear 2 to 3 days after the stroke (Figure 3-31), peaks after 2 to 3 weeks (Figure 3-32), and may persist for up to 10 weeks. Recognizing these areas of enhancement is important to avoid confusing a subacute ischemic lesion with tumors or cerebritis (the distribution of the ischemic infarction in a specific vascular distribution is pivotal in making this distinction).
During the late subacute phase, areas of infarction may appear deceivingly normal in noncontrast scans because of a phenomenon known as “fogging effect.” This phenomenon, ascribed to the development of new capillaries, influx of lipid-laden macrophages, and relative decrease of water content in the evolved infarction, has been reported 2 to 3 weeks after a stroke on CT scans112 and 10 to 14 days after on T2-weighted imaging113 (and to a lesser degree on FLAIR).114 The fogging effect is more likely to compromise diagnostic sensitivity in cases of small cortical infarctions and cerebellar infarctions. Strong enhancement after contrast administration reliably discloses the subacute infarction in these cases.
Chronic infarctions are hypodense on CT scan, hypointense on T1, and hyperintense on T2. FLAIR is particularly useful to differentiate chronic from subacute lesions: in chronic infarctions, FLAIR demonstrates a hypointense cystic core (filled with fluid) with hyperintense borders (from gliosis) (Figure 3-29, E and F, arrows), whereas in subacute strokes, core and borders are hyperintense. DWI may be normal or show a bright signal related to the T2 shine-through phenomenon, but the signal is always bright on the ADC map (high diffusion coefficient because water molecules can move freely in the cystic old infarction).

References

1 Adams HPJr, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.

2 Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674.

3 Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke. Lancet Neurol. 2006;5:755-768.

4 Sobesky J, von Kummer R, Frackowiak M, Zaro WO, Lehnhardt FG, Dohmen C, et al. Early ischemic edema on cerebral computed tomography: its relation to diffusion changes and hypoperfusion within 6 h after human ischemic stroke. A comparison of CT, MRI and PET. Cerebrovasc Dis. 2006;21:336-339.

5 Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999;30:1528-1533.

6 Dippel DW, Du Ry van Beest H, van Kooten F, Koudstaal PJ. The validity and reliability of signs of early infarction on CT in acute ischaemic stroke. Neuroradiology. 2000;42:629-633.

7 Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, et al. Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999;213:150-155.

8 Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.

9 Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.

10 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.

11 Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001;286:2830-2838.

12 Dzialowski I, Hill MD, Coutts SB, Demchuk AM, Kent DM, Wunderlich O, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006;37:973-978.

13 Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke. 2005;36:2110-2115.

14 Coutts SB, Demchuk AM, Barber PA, Hu WY, Simon JE, Buchan AM, et al. Interobserver variation of ASPECTS in real time. Stroke. 2004;35:e103-e105.

15 Demaerschalk BM, Silver B, Wong E, Merino JG, Tamayo A, Hachinski V. ASPECT scoring to estimate >1/3 middle cerebral artery territory infarction. Can J Neurol Sci. 2006;33:200-204.

16 Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke. 1992;23:317-324.

17 Tei H, Uchiyama S, Usui T. Predictors of good prognosis in total anterior circulation infarction within 6 h after onset under conventional therapy. Acta Neurol Scand. 2006;113:301-306.

18 Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, et al. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology. 2006;66:1171-1174.

19 Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezene Y, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry. 2005;76:70-75.

20 Manno EM, Nichols DA, Fulgham JR, Wijdicks EF. Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc. 2003;78:156-160.

21 Linfante I, Llinas RH, Selim M, Chaves C, Kumar S, Parker RA, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke. 2002;33:2066-2071.

22 Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA “dot” sign: A CT marker of acute ischemia. Stroke. 2001;32:84-88.

23 Leary MC, Kidwell CS, Villablanca JP, Starkman S, Jahan R, Duckwiler GR, et al. Validation of computed tomographic middle cerebral artery “dot” sign: an angiographic correlation study. Stroke. 2003;34:2636-2640.

24 Lee TC, Bartlett ES, Fox AJ, Symons SP. The hypodense artery sign. AJNR Am J Neuroradiol. 2005;26:2027-2029.

25 Srinivasan A, Goyal M, Azri FA, Lum C. State-of-the-art imaging of acute stroke. Radiographics. 2006;26(1 Suppl):S75-95.

26 Srinivasan A, Goyal M, Lum C, Nguyen T, Miller W. Processing and interpretation times of CT angiogram and CT perfusion in stroke. Can J Neurol Sci. 2005;32:483-486.

27 Smith WS, Roberts HC, Chuang NA, Ong KC, Lee TJ, Johnston SC, et al. Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol. 2003;24:688-690.

28 Muir KW, Halbert HM, Baird TA, McCormick M, Teasdale E. Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability. J Neurol Neurosurg Psychiatry. 2006;77:334-339.

29 Parsons MW, Pepper EM, Chan V, Siddique S, Rajaratnam S, Bateman GA, et al. Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann Neurol. 2005;58:672-679.

30 Wintermark M, Reichhart M, Cuisenaire O, Maeder P, Thiran JP, Schnyder P, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke. 2002;33:2025-2031.

31 Murphy BD, Fox AJ, Lee DH, Sahlas DJ, Black SE, Hogan MJ, et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke. 2006;37:1771-1777.

32 Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979-985.

33 Sanelli PC, Nicola G, Tsiouris AJ, Ougorets I, Knight C, Frommer B, et al. Reproducibility of postprocessing of quantitative CT perfusion maps. AJR Am J Roentgenol. 2007;188:213-218.

34 Shrier DA, Tanaka H, Numaguchi Y, Konno S, Patel U, Shibata D. CT angiography in the evaluation of acute stroke. AJNR Am J Neuroradiol. 1997;18:1011-1020.

35 Hunter GJ, Silvennoinen HM, Hamberg LM, Koroshetz WJ, Buonanno FS, Schwamm LH, et al. Whole-brain CT perfusion measurement of perfused cerebral blood volume in acute ischemic stroke: probability curve for regional infarction. Radiology. 2003;227:725-730.

36 Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-298.

37 Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke. 2002;33:2206-2210.

38 Lansberg MG, Albers GW, Beaulieu C, Marks MP. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology. 2000;54:1557-1561.

39 Lansberg MG, Norbash AM, Marks MP, Tong DC, Moseley ME, Albers GW. Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Arch Neurol. 2000;57:1311-1316.

40 Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology. 1999;212:333-339.

41 Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology. 1997;49:113-119.

42 Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.

43 Schulz UG, Briley D, Meagher T, Molyneux A, Rothwell PM. Diffusion-weighted MRI in 300 patients presenting late with subacute transient ischemic attack or minor stroke. Stroke. 2004;35:2459-2465.

44 Crisostomo RA, Garcia MM, Tong DC. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke. 2003;34:932-937.

45 Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174-1180.

46 Oppenheim C, Lamy C, Touze E, Calvet D, Hamon M, Mas JL, et al. Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? AJNR Am J Neuroradiol. 2006;27:1782-1787.

47 Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217:331-345.

48 Sobesky J, Zaro WO, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke. 2004;35:2843-2847.

49 Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, et al. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587.

50 Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, et al. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke. 2006;37:98-104.

51 Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, et al. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology. 1999;52:1125-1132.

52 Fisher M. Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator? Ann Neurol. 2006;60:499-501.

53 Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke. 2005;36:1153-1159.

54 Wu O, Christensen S, Hjort N, Dijkhuizen RM, Kucinski T, Fiehler J, et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain. 2006;129(Pt 9):2384-2393.

55 Fiehler J, Knudsen K, Kucinski T, Kidwell CS, Alger JR, Thomalla G, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke. 2004;35:514-519.

56 Sobesky J, Zaro WO, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke. 2005;36:980-985.

57 Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol. 2006;5:661-667.

58 Furlan AJ, Eyding D, Albers GW, Al Rawi Y, Lees KR, Rowley HA, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.

59 Hacke W, Albers G, Al Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.

60 Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.

61 Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299-309.

62 Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62:2187-2192.

63 Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005;36:1700-1704.

64 Saqqur M, Hill MD, Alexandrov AV, Roy J, Schebel M, Krol A, et al. Derivation of power M-mode transcranial Doppler criteria for angiographic proven MCA occlusion. J Neuroimaging. 2006;16:323-328.

65 Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke. 2005;36:2379-2383.

66 Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005;26:618-624.

67 Kim HS, Lee DH, Choi CG, Kim SJ, Suh DC. Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis. AJR Am J Roentgenol. 2006;187:W650-W657.

68 Wilcock DJ, Jaspan T, Worthington BS. Problems and pitfalls of 3-D TOF magnetic resonance angiography of the intracranial circulation. Clin Radiol. 1995;50:526-532.

69 Yang JJ, Hill MD, Morrish WF, Hudon ME, Barber PA, Demchuk AM, et al. Comparison of pre- and postcontrast 3D time-of-flight MR angiography for the evaluation of distal intracranial branch occlusions in acute ischemic stroke. AJNR Am J Neuroradiol. 2002;23:557-567.

70 Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol. 2008;190:1060-1068.

71 Moreno-Romero JA, Segura S, Mascaro JMJr, Cowper SE, Julia M, Poch E, et al. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor. Br J Dermatol. 2007;157:783-787.

72 Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, et al. Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol. 2008;190:736-741.

73 Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.

74 Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170-2178.

75 Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke. 2007;38:69-74.

76 Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.

77 Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432-1438.

78 Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol. 2006;27:1177-1182.

79 Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-1212.

80 Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35:904-911.

81 The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38:2127-2135.

82 Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke. 2005;36:292-296.

83 Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery. 2006;58:458-463.

84 Abou-Chebl A, Bajzer CT, Krieger DW, Furlan AJ, Yadav JS. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke. 2005;36:2286-2288.

85 Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol. 2006;65:352-358. discussion.

86 Wijdicks EF, Rabinstein AA. Absolutely no hope? Some ambiguity of futility of care in devastating acute stroke. Crit Care Med. 2004;32:2332-2342.

87 Barber PA, Demchuk AM, Zhang J, Kasner SE, Hill MD, Berrouschot J, et al. Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis. 2003;16:230-235.

88 Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001;32:2117-2123.

89 Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW. Mass effect and death from severe acute stroke. Neurology. 1997;49:1090-1095.

90 Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999;30:287-292.

91 Manno EM, Nichols DA, Fulgham JR, Wijdicks EF. Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc. 2003;78:156-160.

92 Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829-836.

93 Barber PA, Powers W. MR DWI does not substitute for stroke severity scores in predicting stroke outcome. Neurology. 2006;66:1138-1139.

94 Hand PJ, Wardlaw JM, Rivers CS, Armitage PA, Bastin ME, Lindley RI, et al. MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology. 2006;66:1159-1163.

95 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309-315.

96 Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-222.

97 Averbuch-Heller L, Leigh RJ, Mermelstein V, Zagalsky L, Streifler JY. Ptosis in patients with hemispheric strokes. Neurology. 2002;58:620-624.

98 Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke. 1998;29:2556-2562.

99 Lampl Y, Sadeh M, Lorberboym M. Prospective evaluation of malignant middle cerebral artery infarction with blood-brain barrier imaging using Tc-99m DTPA SPECT. Brain Res. 2006;1113:194-199.

100 Maramattom BV, Bahn MM, Wijdicks EF. Which patient fares worse after early deterioration due to swelling from hemispheric stroke? Neurology. 2004;63:2142-2145.

101 Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005;76:1238-1241.

102 Wijdicks EF, Nichols DA, Thielen KR, Fulgham JR, Brown RDJr., Meissner I, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc. 1997;72:1005-1013.

103 von Campe G, Regli F, Bogousslavsky J. Heralding manifestations of basilar artery occlusion with lethal or severe stroke. J Neurol Neurosurg Psychiatry. 2003;74:1621-1626.

104 Baird TA, Muir KW, Bone I. Basilar artery occlusion. Neurocrit Care. 2004;1:319-329.

105 Bergui M, Stura G, Daniele D, Cerrato P, Berardino M, Bradac GB. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke. 2006;37:145-150.

106 Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke. 2007;38:192-193.

107 Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922-928.

108 Macdonell RA, Kalnins RM, Donnan GA. Cerebellar infarction: natural history, prognosis, and pathology. Stroke. 1987;18:849-855.

109 Jensen MB, St Louis EK. Management of acute cerebellar stroke. Arch Neurol. 2005;62:537-544.

110 Mathew P, Teasdale G, Bannan A, Oluoch-Olunya D. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry. 1995;59:287-292.

111 Lodder J, Krijne-Kubat B, van der Lugt PJ. Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke. Stroke. 1988;19:1482-1484.

112 Chalela JA, Kasner SE. The fogging effect. Neurology. 2000;55:315.

113 Scuotto A, Cappabianca S, Melone MB, Puoti G. MRI “fogging” in cerebellar ischaemia: case report. Neuroradiology. 1997;39:785-787.

114 Uchino A, Sawada YA, Imaizumi T, Mineta T, Kudo S. Report of fogging effect on fast FLAIR magnetic resonance images of cerebral infarctions. Neuroradiology. 2004;46:40-43.